Sakae Muto
Directeur Général chez Kyoto Drug Discovery & Development Co., Ltd.
Provenance du réseau au premier degré de Sakae Muto
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
Kyoto Drug Discovery & Development Co., Ltd.
 Kyoto Drug Discovery & Development Co., Ltd. BiotechnologyHealth Technology Kyoto Drug Discovery & Development Co., Ltd. engages in research and development of pharmaceuticals, diagnostics, regenerative medicine products and medical equipment. The company was founded by Noriyuki Kuno and Kunihiro Musashi on May 15, 2015 and is headquartered in Kyoto, Japan.
3
| Holding Company | Biotechnology | 3 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Sakae Muto via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| Kyoto University | College/University | Corporate Officer/Principal | |
Kyoto University Innovation Capital Co., Ltd.
 Kyoto University Innovation Capital Co., Ltd. Investment ManagersFinance Kyoto University Innovation Capital Co., Ltd. (KYOTO-iCAP) is a Venture Capital firm, a subsidiary of Kyoto University founded in 2014. Kyoto University Innovation Capital Co., Ltd. is headquartered in Kyoto. | Investment Managers | Private Equity Investor | |
Kyoto Fusioneering Ltd.
 Kyoto Fusioneering Ltd. Engineering & ConstructionIndustrial Services Kyoto Fusioneering Ltd. is a startup founded in 2019 by Richard Pearson, Taka Nagao, and Satoshi Konishi. The company is based in Uji, Japan, and uses the world's most advanced technology developed at Kyoto University to achieve its vision of a future powered by nuclear fusion energy. The Japanese company aims to solve the world's challenges by developing the ultimate energy solution, nuclear fusion. The company name "fusioneering" is a combination of "fusion" and "engineering". Taka Nagao has been the CEO since 2019. | Engineering & Construction | Director/Board Member | |
aceRNA Technologies, Inc.
 aceRNA Technologies, Inc. Internet Software/ServicesTechnology Services aceRNA Technologies, Inc. operates a drug development platform. The company is based in Kyoto, Japan. The Japanese company was founded in 2018 by Teruo Suzumu, Hirohide Saito. | Internet Software/Services | Director/Board Member |
Statistiques
Internationale
| Japon | 5 |
Sectorielle
| Consumer Services | 2 |
| Finance | 2 |
| Industrial Services | 2 |
| Technology Services | 2 |
Opérationnelle
| Director/Board Member | 5 |
| Chief Operating Officer | 1 |
| Founder | 1 |
| Corporate Officer/Principal | 1 |
| Private Equity Investor | 1 |
Relations les plus connectées
| Insiders | |
|---|---|
| Nobuhiro Yagi | 4 |
| Akira Kakizuka | 2 |
| Noriyuki Kuno | 1 |
- Bourse
- Insiders
- Sakae Muto
- Connexions Sociétés
